IgG1
Recombi
Biosimilar
Reset all filters

Min CHF:
Max CHF:
  1-30 of 336
Supplier Product name Cat.no. Pack size Price
Anti-BAFF Antibody (belimumab biosimilar) (LymphoStat-B) 12-9104-50 12-9104-100 319,20 370,40
Anti-BCMA Antibody (belantamab biosimilar) (J6M0) 12-9088-50 12-9088-100 319,20 370,40
Recombinant anti-human-IL-1 beta Antibody (Canakinumab Biosimilar) 12-9112-100 370,40
Matuzumab Biosimilar - Research Grade ICH4007-100MG ICH4007-1MG ICH4007-5MG ICH4007-10MG ICH4007-20MG ICH4007-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Ado-trastuzumab emtansine Biosimilar - Research Grade ICH4014-5MG ICH4014-20MG 1'240,00 2'746,00
Aflibercept Biosimilar - Research Grade ICH4015-1MG ICH4015-5MG ICH4015-20MG 678,00 1'240,00 2'746,00
Trastuzumab Biosimilar, HER2 Monoclonal Antibody C009P-1MG C009P-5MG C009P-20MG 162,00 569,00 1'086,00
Anti-Human HER-2 (Trastuzumab) - Fc Muted™ Biotin 12-8008-100 658,00
Anti-Human HER-2 (Trastuzumab) - Fc Muted™ HRP 12-8009-100 756,00
Gantenerumab Biosimilar - Research Grade ICH5009-100MG ICH5009-1MG ICH5009-5MG ICH5009-10MG ICH5009-20MG ICH5009-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Nesvacumab Biosimilar - Research Grade ICH5010-100MG ICH5010-1MG ICH5010-5MG ICH5010-10MG ICH5010-20MG ICH5010-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Girentuximab Biosimilar - Research Grade ICH5013-100MG ICH5013-1MG ICH5013-5MG ICH5013-10MG ICH5013-20MG ICH5013-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Urelumab Biosimilar - Research Grade ICH5015-100MG ICH5015-1MG ICH5015-5MG ICH5015-10MG ICH5015-20MG ICH5015-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Daclizumab Biosimilar - Research Grade ICH5021-100MG ICH5021-1MG ICH5021-5MG ICH5021-10MG ICH5021-20MG ICH5021-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Isatuximab Biosimilar - Research Grade ICH5028-100MG ICH5028-1MG ICH5028-5MG ICH5028-10MG ICH5028-20MG ICH5028-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Dacetuzumab Biosimilar - Research Grade ICH5030-100MG ICH5030-1MG ICH5030-5MG ICH5030-10MG ICH5030-20MG ICH5030-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Lemzoparlimab Biosimilar - Research Grade ICH5034-100MG ICH5034-1MG ICH5034-5MG ICH5034-10MG ICH5034-20MG ICH5034-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Rovalpituzumab Biosimilar - Research Grade ICH5048-100MG ICH5048-1MG ICH5048-5MG ICH5048-10MG ICH5048-20MG ICH5048-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Aprutumab Biosimilar - Research Grade ICH5052-100MG ICH5052-1MG ICH5052-5MG ICH5052-10MG ICH5052-20MG ICH5052-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Bemarituzumab Biosimilar - Research Grade ICH5053-100MG ICH5053-1MG ICH5053-5MG ICH5053-10MG ICH5053-20MG ICH5053-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Codrituzumab Biosimilar - Research Grade ICH5055-100MG ICH5055-1MG ICH5055-5MG ICH5055-10MG ICH5055-20MG ICH5055-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
  1-30 of 336

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
Monday to Friday
08:00 – 12:00
13:00 – 17:00

Technical Support
tech@lucerna-chem.ch
Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

© Copyright 2021 Lucerna-Chem AG, Switzerland

Order Conditions | Privacy Policy | Terms & Conditions | Impressum